This compound is a pharmaceutical intermediate specifically used as a process impurity reference standard for Ibrutinib. It is a stereochemically defined, polycyclic heterocyclic compound containing amide and ether functional groups.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1917333-91-5
Benzyl 3-(hydroxymethyl)piperazine-1-carboxylate
pharmaceutical intermediate
Boc-(2RS,3S)-AHPA
pharmaceutical intermediate
(R)-2-(2,5-Difluorophenyl)pyrrolidine (R)-2-hydroxysuccinate
pharmaceutical intermediate
7-Methoxy-2,4,4-trimethyl-1,3(2H,4H)-isoquinolinedione
pharmaceutical intermediate
3-(4-phenoxyphenyl)-5-[(3R)-1-prop-2-enoylpiperidin-3-yl]-4,5,7,9,13-pentazatricyclo[7.4.0.02,6]trideca-1(13),2(6),3,7-tetraen-12-one
FSCNEJORXHNHBP-HXUWFJFHSA-N
C=CC(=O)N1CCC[C@H](C1)N2C3=C(C(=N2)C4=CC=C(C=C4)OC5=CC=CC=C5)C6=NC(=O)CCN6C=N3
—